The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Dyne Therapeutics, Inc(NASDAQ:DYN) 
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral ...
Website: http://www.dyne-tx.com
Founded: 2017
Full Time Employees: 36
CEO: Joshua T. Brumm
Sector: Other
Industry: Other
Share this website to your friends
Dyne Therapeutics Days Payable Outstanding ttm (DPO)
Dyne Therapeutics Op Cashflow Per Share ttm
Dyne Therapeutics Free Cashflow Per Share ttm
Dyne Therapeutics Cash Per Share ttm
Dyne Therapeutics P/S ratio ttm
Dyne Therapeutics (GAAP) P/E ratio ttm
Dyne Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.